We are live on ! Find out more
LUMO

Lumos Pharma, Inc. Common Stock
LUMO

Delisted

LUMO was delisted on the 11th of December, 2024.

Back to rankings

128 hedge funds and large institutions have $358M invested in Lumos Pharma, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 28 increasing their positions, 36 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

242% more call options, than puts

Call options by funds: $49.1M | Put options by funds: $14.3M

147% more capital invested

Capital invested by funds: $145M → $358M (+$213M)

83% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 18

5% more funds holding

Funds holding: 122 → 128 (+6)

22% less repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 36

Holders
128
Holders Change
+6
Holders Change %
+4.92%
% of All Funds
3.19%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.05%
New
33
Increased
28
Reduced
36
Closed
18
Calls
$49.1M
Puts
$14.3M
Net Calls
+$34.7M
Net Calls Change
+$24.1M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$29.8M
2
DCM
Driehaus Capital Management
Illinois
+$3.38M
3
CCI
Columbus Circle Investors
+$3.31M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$3.16M
5
EI
EAM Investors
California
+$3.04M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$6.98M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$2.71M
3
BIM
Bogle Investment Management
Massachusetts
-$2.53M
4
Renaissance Technologies
Renaissance Technologies
New York
-$1.55M
5
TC
TFS Capital
Pennsylvania
-$1.08M
Name Holding Trade Value Shares
Change 		Change in
Stake
California Public Employees Retirement System
76
California Public Employees Retirement System
California
$441K -$12.7K -89 -4%
ProShare Advisors
77
ProShare Advisors
Maryland
$435K -$74.4K -521 -21%
AG
78
Advisor Group
Arizona
$421K – – –
CG
79
Cutler Group
California
$416K -$117K -816 -30%
BIM
80
Baldwin Investment Management
Pennsylvania
$410K – – –
BIM
81
Bogle Investment Management
Massachusetts
$407K -$2.53M -17,686 -90%
MLICM
82
Metropolitan Life Insurance Company (MetLife)
New York
$391K – – –
MAP
83
Moody Aldrich Partners
Massachusetts
$377K +$248K +1,737 New
EP
84
Elkfork Partners
Oregon
$368K – – –
SSA
85
Schonfeld Strategic Advisors
New York
$351K +$231K +1,615 New
AIG
86
American International Group
New York
$321K +$14K +98 +7%
ANTB
87
AMG National Trust Bank
Colorado
$315K – – –
TI
88
Trexquant Investment
Connecticut
$314K -$102K -717 -33%
GAM
89
Gotham Asset Management
New York
$313K +$206K +1,442 New
TCM
90
Teza Capital Management
Illinois
$312K +$206K +1,439 New
NFA
91
Nationwide Fund Advisors
Ohio
$309K -$21K -147 -9%
Zurich Cantonal Bank
92
Zurich Cantonal Bank
Switzerland
$303K -$5.86K -41 -3%
Invesco
93
Invesco
Georgia
$303K +$200K +1,399 New
UBS AM
94
UBS AM
Illinois
$297K +$196K +1,370 New
FAM
95
Fenimore Asset Management
New York
$297K – – –
TAM
96
Tyers Asset Management
Texas
$268K – – –
CM
97
Crestline Management
Texas
$263K +$174K +1,215 New
CWG
98
C WorldWide Group
Denmark
$261K +$172K +1,204 New
PFS
99
Prospera Financial Services
Texas
$236K -$6.29K -44 -4%
VOYA Investment Management
100
VOYA Investment Management
Georgia
$225K +$148K +1,039 New
2 3
4
5 6

LUMO Hedge Fund Activity: Q1 2017 in Review

128 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Lumos Pharma, Inc. Common Stock (LUMO) for Q1 2017, worth a combined $358M — up 147% from $145M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new LUMO positions and 18 closed out — a net gain of 15 holders — while 28 added to existing stakes and 36 trimmed.

The largest buyer was BlackRock, adding an estimated $29.8M. The largest seller was Millennium Management, cutting an estimated $6.98M.

  • 128 institutional investors held Lumos Pharma, Inc. Common Stock (LUMO) as of Q1 2017, up from 122 in Q4 2016.
  • Funds reported $358M of Lumos Pharma, Inc. Common Stock stock for Q1 2017, up 147% quarter-over-quarter.
  • 33 funds opened new Lumos Pharma, Inc. Common Stock positions in Q1 2017 and 18 closed out, a net change of +15 holders.
  • The largest Lumos Pharma, Inc. Common Stock buyer in Q1 2017 was BlackRock, an estimated $29.8M added.
  • The largest Lumos Pharma, Inc. Common Stock seller in Q1 2017 was Millennium Management, an estimated $6.98M sold.

Based on aggregated 13F filings for Q1 2017.